Printed on 7/20/2026
For informational purposes only. This is not medical advice.
CAM-ICU is a validated bedside delirium screening method designed for critically ill and mechanically ventilated patients. A positive screen requires acute/fluctuating mental status change plus inattention, with either altered consciousness or disorganized thinking.
Formula: Positive if (acute/fluctuating change AND inattention) AND (altered consciousness OR disorganized thinking).
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Before performing CAM-ICU, assess the patient's RASS score. RASS -4 or -5 (unarousable or unresponsive to physical stimulation) = CAM-ICU cannot be performed — document as 'Unarousable — Unable to Assess (UA)'. RASS -3 to +4 = CAM-ICU can be attempted. RASS 0 or higher = full CAM-ICU assessment.
Feature 1 (acute/fluctuating mental status change): Is there an acute change from baseline OR fluctuating mental status over the past 24 hours? Ask family, review nursing notes for fluctuation. Feature 2 (inattention): Ask the patient to squeeze your hand only when you say the letter A in the sequence SAVEAHAART (S-A-V-E-A-H-A-A-R-T). Errors >2 (misses or false positives) = positive. Both Feature 1 AND Feature 2 must be positive to proceed.
Feature 3 (altered level of consciousness): Is RASS anything other than zero (alert and calm)? Any RASS from -3 to +4 = positive. Feature 4 (disorganized thinking): Ask 4 yes/no questions ('Does a stone float on water?', 'Are there fish in the sea?', 'Does one pound weigh more than two?', 'Can you use a hammer to pound a nail?') + follow a 2-step command (hold up 2 fingers, then do same with other hand). Errors >1 = positive. CAM-ICU POSITIVE = Feature 1 + Feature 2 + (Feature 3 OR Feature 4).
ICU nurses
CAM-ICU is the standard tool for twice-daily delirium screening in the ICU as recommended by PADIS 2018 guidelines. Daily assessment allows early detection of delirium onset, tracking of delirium duration and resolution, and evaluation of treatment response.
Intensivists
CAM-ICU positive results directly inform sedation strategy — positive delirium in a sedated patient may prompt reducing benzodiazepines, transitioning to dexmedetomidine, and implementing non-pharmacological prevention measures. PADIS guidelines integrate CAM-ICU with sedation targets (RASS 0 to -2).
ICU teams
Serial CAM-ICU assessments document the trajectory of delirium — from positive (delirious) to negative (resolved). This guides decisions about medication adjustments, delirium-specific interventions, and readiness for weaning and extubation.
Clinical researchers
CAM-ICU is the validated research standard for defining ICU delirium in clinical trials. Its use enables standardized delirium incidence measurement, comparison across studies, and investigation of delirium risk factors and outcomes (mortality, long-term cognitive impairment).
Bedside nurses
CAM-ICU results provide families with objective, validated information about their loved one's delirium status. Communicating 'the delirium screen was positive today but negative yesterday' is more informative and less frightening than subjective descriptions, and helps families understand why their family member seems confused.
ICU pharmacists
PADIS 2018 guidelines recommend using CAM-ICU or ICDSC for routine ICU delirium monitoring. ICU pharmacists use CAM-ICU results to guide medication review for deliriogenic drugs (benzodiazepines, anticholinergics, opioids at high doses) and to recommend dexmedetomidine as a delirium-reducing sedation alternative.
The logical structure is critical: Features 1 and 2 are both REQUIRED. If either is absent, CAM-ICU is negative regardless of Features 3 and 4. After confirming Features 1 and 2 are positive, only ONE of Feature 3 or Feature 4 needs to be positive for the overall CAM-ICU to be positive.
RASS -4 (deep sedation, responds only to physical stimulation with movement) and RASS -5 (unarousable, no response to any stimulation) are NOT assessable with CAM-ICU. Document 'UA (Unarousable)' not 'CAM-ICU negative.' A patient who is RASS -4/-5 on propofol infusion cannot be assessed for delirium until sedation is lightened.
Delirium in the ICU is not just 'confusion' — it is independently associated with 3× increased in-hospital mortality, 10-day longer hospital stays, and long-term cognitive impairment persisting for months to years after ICU discharge (Post-Intensive Care Syndrome). Early recognition and prevention of delirium are critical quality measures.
ABCDEF Bundle: A = Assess and Manage Pain (CPOT/BPS); B = Breathing Trials (daily SAT + SBT); C = Choice of Analgesia and Sedation (minimize benzodiazepines, target RASS 0 to -2); D = Delirium assessment, prevention, treatment (CAM-ICU); E = Early Mobility and Exercise; F = Family Engagement. Implementation reduces delirium duration, ventilator days, and ICU mortality.
Evidence-based non-pharmacological interventions: reorientation (clocks, calendars, familiar voices); sleep hygiene (day/night differentiation, noise reduction, clustered care); ensure patients have hearing aids and glasses; early mobility (sitting, standing, walking when safe); minimize deliriogenic medications (benzodiazepines, anticholinergics, polypharmacy). These interventions reduce delirium incidence in RCTs.
Despite widespread use, haloperidol and quetiapine have NOT been shown to reduce delirium incidence, duration, or mortality in multiple large ICU RCTs (HOPE-ICU, MIND-USA, AID-ICU). Antipsychotics are used for symptomatic management of hyperactive delirium (agitation, pulling lines) but are not preventive or curative. Reserve for severe agitation causing patient harm.
Multiple trials (MENDS, SEDCOM, MENDS2) show dexmedetomidine as the primary sedation agent results in fewer delirium-positive days compared to lorazepam or midazolam. Dexmedetomidine also provides analgesia (reduces opioid requirements) and allows more cooperative, arousable sedation. Preferred for light sedation targets in mechanically ventilated patients.
ICU delirium subtypes: hyperactive (~25% — agitation, attempting to remove lines, combative), hypoactive (~50% — withdrawal, reduced responsiveness, appearing 'cooperative'), mixed (~25%). Hypoactive delirium is the most common and most frequently missed because the patient appears calm and 'doing well.' CAM-ICU systematically detects hypoactive delirium that might otherwise be attributed to sedation or fatigue.
Before reaching for antipsychotics, assess for reversible precipitants: untreated pain (CPOT score >2), urinary retention (post-void residual >300 mL, bladder scan), fecal impaction, electrolyte abnormalities (Na, Mg, Ca, glucose), infection (new fever, elevated WBC, positive cultures), medication-induced delirium (benzodiazepines, anticholinergics, steroids at high doses, opioids at high doses).
CAM-ICU published by Ely et al. (JAMA 2001) from 96 mechanically ventilated patients. Sensitivity 93-100%, specificity 89-100% vs psychiatrist gold standard. PADIS Guidelines (Devlin et al., Crit Care Med 2018) recommend CAM-ICU or ICDSC for routine ICU delirium monitoring. ICU delirium incidence: 60-80% in mechanically ventilated patients. Delirium and 6-month mortality: Ely et al. (JAMA 2004). Dexmedetomidine reducing delirium: MENDS and SEDCOM trials.
Use for routine delirium surveillance in ICU and high-acuity patients, especially when communication is limited.
CAM-ICU is a screening test; interpretation can be affected by sedation depth, language barriers, and severe baseline neurologic deficits.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Screen for delirium using the CAM (Confusion Assessment Method). Gold standard with ~94% sensitivity and ~89% specificity. Requires acute onset + inattention, plus disorganized thinking or altered consciousness.
OpenEmergencyCalculate the Glasgow Coma Scale score to assess level of consciousness. Used worldwide in emergency medicine and trauma assessment.
OpenEmergencyCalculate the APACHE II score to predict ICU mortality risk. Uses acute physiological variables, age, and chronic health status.
OpenEmergencyCalculate the SOFA score to assess organ dysfunction severity in critically ill patients. Scores range from 0 to 24 across six organ systems.
Open